LIMA1 and cancer: From earlier studies, one of the most significant findings concerning EPLIN is that it regulates actin dynamics by colocalising with actin filaments and other actin structure regulators and cross-linking actin filaments, inhibiting branched nucleation through Arp2/3, further to affecting cells’ motility and migration in order to promote cancer development [4,7].